MIAMI, FL / ACCESS Newswire / December 17, 2025 / KIFFIK Biomedical announced today the successful close of its Series A financing, completed ahead of schedule and significantly oversubscribed. The ...

As per SNS Insider Research, The Global Syndromic Multiplex Diagnostics Market Growth is Driven by Advancements in Molecular Diagnostics, Rising Burden of Infectious Diseases and Growing Demand for ...

As part of this agreement, Zydus will exclusively market, create awareness, access and engage clinicians on three of Myriad Genetics' broadly validated diagnostic platforms, MyRisk Hereditary Cancer ...

Zydus Lifesciences Limited ( ($IN:ZYDUSLIFE) ) has issued an announcement. Zydus Lifesciences has signed an exclusive agreement with US-based ...

Zydus Lifesciences has partnered with US-based Myriad Genetics to bring advanced cancer risk and prognostic tests to India, aiming to boost personalized oncology care.

The world of medical testing is always changing, and point-of-care molecular diagnostics are a big part of that. These tests let us find out what’s going on with a patient’s health right there, ...

When disease begins forming inside the human body, something subtle happens long before symptoms appear. Individual molecules ...

So, QuidelOrtho is making some big moves in the diagnostics world, and a lot of it has to do with a company called LEX Diagnostics. It seems like they’re really trying to speed things up, especially ...

Linking nanopores with nanofluidic chips can slow molecules, cut noise, scale measurements, and enable early disease ...

Colorectal cancer, or CRC, is the world's second most lethal cancer based on the number of deaths, and is the third most ...

The VYZOV Prize has expanded its international footprint in 2025, drawing applications from researchers across 40 countries ...

Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven ...